查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026914

總體基因體學市場預測至2034年－按產品類型、技術、應用、最終用戶和地區分類的全球分析

Metagenomics Market Forecasts to 2034 - Global Analysis By Product Type (Kits & Reagents, Software, Sequencing & Data Analytics Services and Other Product Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球總體基因體學市場規模將達到 33 億美元，並在預測期內以 18.5% 的複合年成長率成長，到 2034 年將達到 129 億美元。

對從環境樣本中提取的遺傳物質進行研究稱為總體基因體學。這項研究旨在探討基因和微生物代謝途徑，被認為是闡明微生物群落結構的重要工具。總體基因體學提供了一種強大的分析方法，能夠幫助我們了解整個生命世界。如今，科技的進步使得研究人員能夠獲得種類繁多的微生物多樣性，並更深入地了解微生物生態系統。

根據美國國家人類基因組實驗室2017年7月發布的報告，單一人類基因組定序產生的數據量約為743Terabyte（743,000千兆位元組）。與2001年人類基因組計畫啟動時產生的16.2千兆位元組相比，這是一個顯著的成長。

臨床應用的需求日益成長

總體基因體學因其在疾病診斷、個人化醫療以及闡明人類微生物組在健康和疾病中的作用而日益受到臨床實踐的關注。它能夠對微生物群落進行全面分析，有助於疾病識別、治療方法最佳化和藥物研發。這些生物標記有望成為多種疾病的診斷指標和治療標靶，進而推動市場成長。

倫理和監管問題

管理機密資訊會引發倫理和隱私方面的擔憂，尤其是在使用人類微生物組資料時。此外，各地在基因和微生物數據使用方面的法律差異也會影響商業化和研究活動。而且，這些數據的管理、儲存和解讀都極具挑戰性，需要專業知識，這進一步阻礙了市場擴張。

日益增強的意識和研究努力

人們日益關注微生物組對農業、人類健康和環境的影響，這推動了相關研究計畫和資金的增加。由於技術和分析方法的不斷進步，總體基因體學領域正在迅速發展。新的發現和見解不斷加深我們對微生物群落的理解。隨著政府機構、學術機構和私人企業投入的資金不斷增加，總體基因體學研究市場也不斷擴大。

定序技術高成本

數據分析、計算資源和定序技術的高昂成本是阻礙小規模研究機構和預算有限的公司利用這些技術的主要障礙。元基因組學研究會產生大量數據，需要先進的計算基礎設施和生物資訊專業知識。評估多樣化微生物群落的挑戰之一是其複雜性，阻礙了市場擴張。

新冠疫情的影響：

導致新冠肺炎的SARS-CoV-2病毒的識別和檢測得益於總體基因體學。研究人員利用元基因組定序來追蹤病毒突變、發現新株並闡明病毒的傳播途徑。透過揭示病毒的基因組成，總體基因體學為疫苗研發做出了貢獻。科學家利用這些知識，更深入了解病毒隨時間推移的變異情況，並開發出更有效的疫苗。

在預測期內，試劑盒和試劑細分市場預計將成為最大的細分市場。

在預測期內，試劑盒和試劑細分市場預計將佔據最大佔有率。這些試劑盒包含標準化的方法和試劑，確保實驗過程的統一性和可重複性，從而減少實驗間以及研究人員間的差異。這些試劑盒針對特定類型的樣本和定序平台進行設計，因此能夠更有效地發揮作用。它們通常還包含專門針對難處理樣本物種設計的組件，從而提高DNA的產量和純度。

在預測期內，預計鳥槍定序領域將呈現最高的複合年成長率。

預計在預測期內，鳥槍定序片段的複合年成長率（CAGR）將最高。鳥槍法定定序是一種無偏差的方法，因為它不需要預先了解樣本中包含的物種。由於它可以捕獲所有遺傳訊息，因此有可能發現新的、意想不到的物種。這有助於建構假設，從而進行更有針對性的研究。透過辨識族群的遺傳潛力，研究人員可以專注於特定的基因或通路，進行更深入的研究。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。總體基因體學對這些棲息地遺傳多樣性的廣泛分析，有助於了解其中存在的各種生物。該地區也在推動技術進步。定序和計算技術的進步使得對複雜微生物群落進行更深入的研究和理解成為可能，加速了元基因組研究的發展。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。在中國、印度和日本等國家，總體基因體學的應用將有助於研究土壤健康狀況、發現對農業有益的微生物，以及解決河流和海洋污染等環境問題。總體基因體學在了解人口稠密的大都會圈的微生物群落、促進疾病監測以及研究人類微生物組的多樣性方面發揮著至關重要的作用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球總體基因體學市場：依產品類型分類

  • 試劑盒和試劑
  • 軟體
  • 定序和數據分析服務
  • 樣品製備工具包
  • 樣本萃取試劑盒
  • 元基因組定序盒
  • 其他產品類型

第6章 全球宏總體基因體學市場：依技術分類

  • 16S定序
  • 全基因組定序
  • 霰彈槍定序
  • 宏轉錄組學
  • 其他技術

第7章 全球宏總體基因體學市場：依應用分類

  • 生物表面活性劑和抗生素的生產
  • 臨床診斷
  • 微生物多樣性
  • 生物修復和分解
  • 其他用途

第8章：全球宏總體基因體學市場：依最終用戶分類

  • 病理檢查室
  • 學術研究機構
  • 研究所
  • 生物技術
  • 製藥
  • 食品與營養
  • 其他最終用戶

第9章 全球總體基因體學市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Agilent Technologies
  • BGI Group
  • Bio-Rad Laboratories
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • IntegraGen
  • Merck KGaA
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare Pvt. Ltd.
Product Code: SMRC24616

According to Stratistics MRC, the Global Metagenomics Market is accounted for $3.3 billion in 2026 and is expected to reach $12.9 billion by 2034 growing at a CAGR of 18.5% during the forecast period. The study of genetic material extracted from environmental samples is known as metagenomics. To investigate genes and microbial pathways, the research is characterized as a tool for the microbial community. It offers a strong lens with the capacity to comprehend the entirety of the living universe. Researchers may now access a wide range of microbial variety and gain a better grasp of the microbial ecology thanks to technology.

According to a report from the National Human Genome Research Institute as of July 2017, approximately 743 terabytes (743,000 gigabytes) of data are generated during the sequencing of a single human genome, compared to 16.2 gigabytes at the beginning of the human genome project in 2001.

Market Dynamics:

Driver:

Rising demand in clinical applications

Metagenomics has gained traction in clinical settings for disease diagnostics, personalized medicine, and understanding the human microbiome's role in health and disease. It allows for comprehensive analysis of microbial communities, aiding in disease identification, treatment optimization, and drug development. These biomarkers could potentially serve as diagnostic indicators or therapeutic targets for various conditions. These are the factors propelling the growth of the market.

Restraint:

Ethical and regulatory concerns

The management of sensitive information raises ethical and privacy concerns that must be addressed, particularly with relation to the use of human microbiome data. Furthermore, regional differences in the laws governing the use of genetic and microbiological data have an effect on commercialization and research initiatives. Furthermore, managing, preserving, and deciphering this data might be difficult and call for specific knowledge, which could further impede the market's expansion.

Opportunity:

Increasing awareness and research initiatives

Growing apprehension about the effects of microbiomes on agriculture, human health, and the environment has resulted in more financing and research projects. The area of metagenomics is developing quickly due to ongoing advances in technology and analytical techniques. The understanding of microbial communities is always growing as a result of new findings and insights. The market for metagenomics research is growing as a result of increased funding from governmental bodies, academic institutions, and commercial businesses.

Threat:

High costs associated with sequencing technologies

The high expense of data analysis, computer resources, and sequencing technology is a major hurdle that prevents smaller research organizations or businesses with tighter budgets from using them. Metagenomic investigations create enormous amounts of data, which calls for advanced computing infrastructure and bioinformatics knowledge. One of the challenges in evaluating various microbial communities is their complexity. This is the element impeding the market's expansion.

Covid-19 Impact:

us that causes COVID-19, SARS-CoV-2, has been identified and detected thanks in large part to metagenomics. Metagenomic sequencing has been utilized by researchers to track mutations, find new strains, and comprehend the virus's dissemination. Because it sheds light on the virus's genetic composition, metagenomics has aided in the creation of vaccines. Scientists have used this knowledge to better understand how the virus could change over time and develop vaccinations, which has improved vaccine effectiveness.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. Standardized methods and reagents are provided by these kits, guaranteeing uniformity and repeatability in experimental processes. This lessens variation across experiments and amongst researchers. These kits work better because they are tailored for particular kinds of samples or sequencing platforms. They frequently have parts designed specifically for difficult sample kinds, enhancing DNA yield and purity.

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period. Without requiring prior knowledge of the species present in the sample, shotgun sequencing is impartial. Since it captures all genetic information, new and unexpected species can be found. It helps to produce hypotheses for more focused research. Researchers might concentrate on particular genes or pathways of interest for in-depth studies by identifying a community's genetic potential.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Understanding the wide variety of organisms present is made easier by the extensive analysis of genetic diversity provided by metagenomics in these habitats. The area is leading the way in technical advancements. Technological developments in sequencing and computational techniques facilitate metagenomic research by enabling deeper examination and comprehension of intricate microbial populations.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Researching soil health, discovering useful microbes for agriculture, and addressing environmental issues like pollution in rivers and seas in nations such as China, India, and Japan are all made easier by the use of metagenomics. Metagenomics plays a crucial role in comprehending the microbial communities found in highly populated metropolitan regions, facilitating disease surveillance, and examining the variety of the human microbiome.

Key players in the market

Some of the key players in Metagenomics market include Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., IntegraGen, Merck KGaA, Novogene Co., Ltd., Oxford Nanopore Technologies, PerkinElmer, Inc., Promega Corporation, Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc. and Trivitron Healthcare Pvt. Ltd.

Key Developments:

In September 2022, Illumina, Inc. (US) launched the NovaSeq X series production-scale sequencers, which are capable of generating more than 20,000 whole genomes per year (which is 2.5 times the throughput of prior sequencers from Illumina).

In September 2021, Thermo Fisher Scientific, Inc. (US) and AstraZeneca(UK) co-developed an NGS-based companion diagnostic. The collaboration was focused on commercializing NGS-based diagnostics in Russia.

Product Types Covered:

  • Kits & Reagents
  • Software
  • Sequencing & Data Analytics Services
  • Library Preparation Kits
  • Sample Extraction Kits
  • Metagenomic Sequencing Kits
  • Other Product Types

Technologies Covered:

  • 16S Sequencing
  • Whole Genome Sequencing
  • Shotgun Sequencing
  • Metatranscriptomics
  • Other Technologies

Applications Covered:

  • Bio Surfactants and Antibiotics Production
  • Clinical Diagnostics
  • Microbial Diversity
  • Bioremediation and Degradation
  • Other Applications

End Users Covered:

  • Pathology Laboratories
  • Academic and Research Institutes
  • Biotechnology
  • Pharmaceutical
  • Food & Nutrition
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Metagenomics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Kits & Reagents
  • 5.3 Software
  • 5.4 Sequencing & Data Analytics Services
  • 5.5 Library Preparation Kits
  • 5.6 Sample Extraction Kits
  • 5.7 Metagenomic Sequencing Kits
  • 5.8 Other Product Types

6 Global Metagenomics Market, By Technology

  • 6.1 Introduction
  • 6.2 16S Sequencing
  • 6.3 Whole Genome Sequencing
  • 6.4 Shotgun Sequencing
  • 6.5 Metatranscriptomics
  • 6.6 Other Technologies

7 Global Metagenomics Market, By Application

  • 7.1 Introduction
  • 7.2 Bio Surfactants and Antibiotics Production
  • 7.3 Clinical Diagnostics
  • 7.4 Microbial Diversity
  • 7.5 Bioremediation and Degradation
  • 7.6 Other Applications

8 Global Metagenomics Market, By End User

  • 8.1 Introduction
  • 8.2 Pathology Laboratories
  • 8.3 Academic and Research Institutes
  • 8.4 Research Laboratories
  • 8.5 Biotechnology
  • 8.6 Pharmaceutical
  • 8.7 Food & Nutrition
  • 8.8 Other End Users

9 Global Metagenomics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 BGI Group
  • 11.3 Bio-Rad Laboratories
  • 11.4 Eurofins Scientific
  • 11.5 F. Hoffmann-La Roche Ltd.
  • 11.6 Illumina, Inc.
  • 11.7 IntegraGen
  • 11.8 Merck KGaA
  • 11.9 Novogene Co., Ltd.
  • 11.10 Oxford Nanopore Technologies
  • 11.11 PerkinElmer, Inc.
  • 11.12 Promega Corporation
  • 11.13 Qiagen
  • 11.14 Takara Bio, Inc.
  • 11.15 Thermo Fisher Scientific, Inc.
  • 11.16 Trivitron Healthcare Pvt. Ltd.

List of Tables

  • Table 1 Global Metagenomics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Metagenomics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Metagenomics Market Outlook, By Kits & Reagents (2023-2034) ($MN)
  • Table 4 Global Metagenomics Market Outlook, By Software (2023-2034) ($MN)
  • Table 5 Global Metagenomics Market Outlook, By Sequencing & Data Analytics Services (2023-2034) ($MN)
  • Table 6 Global Metagenomics Market Outlook, By Library Preparation Kits (2023-2034) ($MN)
  • Table 7 Global Metagenomics Market Outlook, By Sample Extraction Kits (2023-2034) ($MN)
  • Table 8 Global Metagenomics Market Outlook, By Metagenomic Sequencing Kits (2023-2034) ($MN)
  • Table 9 Global Metagenomics Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 10 Global Metagenomics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 11 Global Metagenomics Market Outlook, By 16S Sequencing (2023-2034) ($MN)
  • Table 12 Global Metagenomics Market Outlook, By Whole Genome Sequencing (2023-2034) ($MN)
  • Table 13 Global Metagenomics Market Outlook, By Shotgun Sequencing (2023-2034) ($MN)
  • Table 14 Global Metagenomics Market Outlook, By Metatranscriptomics (2023-2034) ($MN)
  • Table 15 Global Metagenomics Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 16 Global Metagenomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 17 Global Metagenomics Market Outlook, By Bio Surfactants and Antibiotics Production (2023-2034) ($MN)
  • Table 18 Global Metagenomics Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 19 Global Metagenomics Market Outlook, By Microbial Diversity (2023-2034) ($MN)
  • Table 20 Global Metagenomics Market Outlook, By Bioremediation and Degradation (2023-2034) ($MN)
  • Table 21 Global Metagenomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 22 Global Metagenomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 23 Global Metagenomics Market Outlook, By Pathology Laboratories (2023-2034) ($MN)
  • Table 24 Global Metagenomics Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 25 Global Metagenomics Market Outlook, By Research Laboratories (2023-2034) ($MN)
  • Table 26 Global Metagenomics Market Outlook, By Biotechnology (2023-2034) ($MN)
  • Table 27 Global Metagenomics Market Outlook, By Pharmaceutical (2023-2034) ($MN)
  • Table 28 Global Metagenomics Market Outlook, By Food & Nutrition (2023-2034) ($MN)
  • Table 29 Global Metagenomics Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.